Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Relapsed Or Refractory Multiple Myeloma”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)WithdrawnNCT06352866
What this trial is testing

Siltuximab for Cytokine Release Syndrome Prophylaxis Prior to tx w/ Teclistamab in RRMM

Who this might be right for
Multiple MyelomaCytokine Release SyndromeRefractory Multiple Myeloma+1 more
Jack Khouri, MD
Early research (Phase 1)Ended earlyNCT05027594
What this trial is testing

Ph I Study in Adult Patients With Relapsed or Refractory Multiple Myeloma

Who this might be right for
Multiple Myeloma
Nerviano Medical Sciences 5
Early research (Phase 1)Study completedNCT02831686
What this trial is testing

Test the Combination of Selinexor (KPT-330), Ixazomib, and Dexamethasone in Patients With Myeloma

Who this might be right for
Multiple MyelomaRelapsed and/or Refractory Multiple Myeloma
Memorial Sloan Kettering Cancer Center 18
Not applicableStudy completedNCT00534118
What this trial is testing

Donor Lymphocyte Infusion in Treating Patients With Recurrent or Persistent Hematologic Cancer After Donor Stem Cell Transplant

Who this might be right for
LeukemiaLymphomaMultiple Myeloma and Plasma Cell Neoplasm+1 more
Roswell Park Cancer Institute 39
Testing effectiveness (Phase 2)Active Not RecruitingNCT04790474
What this trial is testing

Ixazomib-pomalidomide-dexamethasone as Second or Third-line Combination Treatment for Patients With Relapsed and Refractory Multiple Myeloma Previously Treated With Daratumumab, Lenalidomide and Bortezomib

Who this might be right for
Multiple Myeloma in RelapseRefractory Multiple Myeloma
Tel-Aviv Sourasky Medical Center 61
Early research (Phase 1)Ended earlyNCT03755154
What this trial is testing

Study of a New Intravenous Drug, Called S65487, in Patients With Acute Myeloid Leukemia, Non Hodgkin Lymphoma, Multiple Myeloma or Chronic Lymphocytic Leukemia

Who this might be right for
Relapsed or Refractory Acute Myeloid LeukemiaRelapsed or Refractory Non-Hodgkin LymphomaRelapsed or Refractory Multiple Myeloma+1 more
Institut de Recherches Internationales Servier 60
Early research (Phase 1)Looking for participantsNCT06348108
What this trial is testing

Talquetamab in Combination With Iberdomide and Dexamethasone for Relapsed or Refractory Multiple Myeloma

Who this might be right for
Multiple MyelomaRefractory Multiple MyelomaRelapsed Multiple Myeloma
Alfred Chung, MD 32
Testing effectiveness (Phase 2)Study completedNCT00375791
What this trial is testing

Efficacy of Perifosine Alone and in Combination With Dexamethasone for Patients With Multiple Myeloma

Who this might be right for
Multiple Myeloma
AEterna Zentaris 67
Large-scale testing (Phase 3)Active Not RecruitingNCT06158841
What this trial is testing

Study Assessing Activity of Intravenous (IV) Etentamig Monotherapy Versus Standard Available Therapies in Adult Participants With Relapsed or Refractory Multiple Myeloma

Who this might be right for
Multiple Myeloma
AbbVie 421
Early research (Phase 1)Study completedNCT01575925
What this trial is testing

Study of Pomalidomide to Evaluate the Pharmacokinetics and Safety for Patients With Multiple Myeloma and Impaired Renal Function (POM Renal)

Who this might be right for
Multiple MyelomaRenal Impairment
Celgene 25
Testing effectiveness (Phase 2)Study completedNCT00915408
What this trial is testing

A Dose Escalation Study of the Combination of Lenalidomide (Revlimid®), Dexamethasone and Cyclophosphamide in Patients Refractory or Relapsing From Stable Disease With Multiple Myeloma

Who this might be right for
Multiple Myeloma
King's College Hospital NHS Trust 32
Large-scale testing (Phase 3)Study completedNCT00017602
What this trial is testing

Dexamethasone With or Without Oblimersen in Treating Patients With Relapsed or Refractory Multiple Myeloma

Who this might be right for
Multiple Myeloma and Plasma Cell Neoplasm
Genta Incorporated
Early research (Phase 1)Study completedNCT02514239
What this trial is testing

Phase I Dose Escalation of i.v. BI 836909 Monotherapy in Last Line Multiple Myeloma Patients

Who this might be right for
Multiple Myeloma
Boehringer Ingelheim 43
Early research (Phase 1)Study completedNCT00996957
What this trial is testing

Study of ACE-041 in Patients With Advanced Solid Tumors or Relapsed/Refractory Multiple Myeloma

Who this might be right for
Advanced Solid TumorsMultiple Myeloma
Acceleron Pharma, Inc., a wholly-owned subsidiary of Merck & Co., Inc., Rahway, NJ USA 37
Testing effectiveness (Phase 2)UnknownNCT00008164
What this trial is testing

Umbilical Cord Blood and Placental Blood Transplantation in Treating Patients With Hematologic Cancer or Aplastic Anemia

Who this might be right for
Childhood Langerhans Cell HistiocytosisLeukemiaLymphoma+3 more
Herbert Irving Comprehensive Cancer Center 30
Testing effectiveness (Phase 2)Study completedNCT01348919
What this trial is testing

Delanzomib (CEP-18770) in Combination With Lenalidomide and Dexamethasone in Relapsed or Refractory Multiple Myeloma

Who this might be right for
Multiple Myeloma
Teva Branded Pharmaceutical Products R&D, Inc. 11
Testing effectiveness (Phase 2)Study completedNCT00096837
What this trial is testing

Motexafin Gadolinium for the Treatment of Relapsed or Refractory Multiple Myeloma

Who this might be right for
Multiple Myeloma
Pharmacyclics LLC. 25
Testing effectiveness (Phase 2)Study completedNCT00558896
What this trial is testing

CC-4047 and Dexamethasone in Treating Patients With Relapsed or Refractory Multiple Myeloma or Amyloidosis

Who this might be right for
Multiple Myeloma and Plasma Cell Neoplasm
Mayo Clinic 378
Early research (Phase 1)Looking for participantsNCT05546723
What this trial is testing

LMY-920 for Treatment of Relapsed or Refractory Myeloma

Who this might be right for
Multiple Myeloma, RefractoryMultiple Myeloma in Relapse
Luminary Therapeutics 30
Testing effectiveness (Phase 2)Looking for participantsNCT06948084
What this trial is testing

Testing the Investigational Medication Combination of Daratumumab and Teclistamab Compared to the Usual Treatment (Daratumumab, Pomalidomide, Dexamethasone or Daratumumab, Carfilzomib, Dexamethasone) for Patients With High-risk Multiple Myeloma Refractory or in First Relapse

Who this might be right for
Recurrent Multiple MyelomaRefractory Multiple Myeloma
National Cancer Institute (NCI) 80
Next Page